Swipe om te navigeren naar een ander artikel
Huntington’s disease (HD) is an autosomal dominant neurodegenerative disease associated with motor, behavioral, and cognitive deficits. The hallmark symptom of HD, chorea, is often the focus of HD clinical trials. Unfortunately, there are no self-reported measures of chorea. To address this shortcoming, we developed a new measure of chorea for use in HD, HDQLIFE Chorea.
Qualitative data and literature reviews were conducted to develop an initial item pool of 141 chorea items. An iterative process, including cognitive interviews, expert review, translatability review, and literacy review, was used to refine this item pool to 64 items. These 64 items were field tested in 507 individuals with prodromal and/or manifest HD. Exploratory and confirmatory factor analyses (EFA and CFA, respectively) were conducted to identify a unidimensional set of items. Then, an item response theory graded response model (GRM) and differential item functioning analyses were conducted to select the final items for inclusion in this measure.
EFA and CFA supported the retention of 34 chorea items. GRM and DIF supported the retention of all of these items in the final measure. GRM calibration data were used to inform the selection of a 6-item, static short form and to program the HDQLIFE Chorea computer adaptive test (CAT). CAT simulation analyses indicated a 0.99 correlation between the CAT scores and the full item bank.
The new HDQLIFE Chorea CAT and corresponding 6-item short form were developed using established rigorous measurement development standards; this is the first self-reported measure developed to evaluate the impact of chorea on HRQOL in HD. This development work indicates that these measures have strong psychometric properties; future work is needed to establish test–retest reliability and responsiveness to change.
Log in om toegang te krijgen
Met onderstaand(e) abonnement(en) heeft u direct toegang:
Read, J., Jones, R., Owen, G., Leavitt, B. R., Coleman, A., Roos, R. A., et al. (2013). Quality of life in Huntington’s disease: A comparative study investigating the impact for those with pre-manifest and early manifest disease, and their partners. Journal of Huntingtons Disease, 2(2), 159–175.
Huntington Study Group. (1996). Unified Huntington’s Disease Rating Scale: Reliability and consistency. Movement Disorders, 11(2), 136–142. CrossRef
US Department of Health and Human Services: Food and Drug Administration. (2006). Guidance for industry: Patient-reported outcome measures: Use in medical product development to support labeling claims: Draft guidance. Health and Quality of Life Outcomes, 4.
Cella, D., Nowinski, C., Peterman, A., Victorson, D., Miller, D., Lai, J.-S., & Moy, C. (2011). The neurology quality of life measurement (Neuro-QOL) initiative. Archives of Physical Medicine and Rehabilitation, Supplement, 92(Suppl 1), S28–S36. CrossRef
Gershon, R. C., Lai, J. S., Bode, R., Choi, S., Moy, C., Bleck, T., Miller, D., Peterman, A., & Cella, D. (2011). Neuro-QOL: Quality of life item banks for adults with neurological disorders: Item development and calibrations based upon clinical and general population testing. Quality of Life Research.
Cella, D., Riley, W., Stone, A., Rothrock, N., Reeve, B., Yount, S., et al. (2010). The patient-reported outcomes measurement information system (PROMIS) developed and tested in its first wave of adult self-reported health outcome item banks: 2005–2008. Journal of Clinical Epidemiology, 63, 1179–1194. CrossRefPubMedPubMedCentral
PROMIS ® Instrument Development and Psychometric Evaluation Scientific Standards. http://www.nihpromis.org/Documents/PROMIS_Standards_050212.pdf.
Hanauer, D. A., Mei, Q., Law, J., Khanna, R., & Zheng, K. (2015). Supporting information retrieval from electronic health records: A report of University of Michigan’s 9-year experience in developing and using the electronic medical record search engine (EMERSE). Journal of Biomedical Informatics, 55, 290–300. CrossRefPubMedPubMedCentral
Carlozzi, N. E., Schilling, S. G., J.-S., L., Paulsen, J. S., Hahn, E. A., Perlmutter, J. S., Ross, C. A., Downing, N. R., Kratz, A. L., McCormack, M. K., Nance, M. A., Quaid, K. A., Stout, J., Gershon, R. C., Ready, R., Miner, J. A., Barton, S. K., Perlman, S. L., Rao, S. M., Frank, S., Shoulson, I., Marin, H., Geschwind, M. D., Dayalu, P., Foroud, T., Goodnight, S. M., & Cella, D. (Under Review). HDQLIFE: Development and assessment of health-related quality of life in Huntington disease (HD). Quality of Life Research.
Kline, R. B. (2005). Principles and practice of structural equation modeling (2nd ed.). New York: Guilford Press.
Hu, L. T., & Bentler, P. M. (1999). Cutoff criteria for fit indexes in covariance structure analysis: Conventional criteria versus new alternatives. Structural Equation Modeling-a Multidisciplinary Journal, 6(1), 1–55. CrossRef
Hatcher, L. (1994). A step-by-step approach to using SAS for factor analysis and structural equation modeling. Cary, NC: SAS Institute Inc.
McDonald, R. P. (1999). Test theory: A unified treatment. Mahwah, NJ: Lawrence Erlbaum Associates Inc.
Muthén, L. K., & Muthén, B. O. (2011). Mplus user’s guide. Los Angeles, CA: Muthén & Muthén.
Samejima, F., van der Liden, W. J., & Hambleton, R. (1996). The graded response model. In W. J. van der Liden (Ed.), Handbook of modern item response theory (pp. 85–100). NewYork, NY: Springer.
Cai, L., Thissen, D., & du Toit, S. H. C. (2011). IRTPRO for windows [computer software]. Lincolnwood, IL: Scientific Software International.
Choi, S. W. (2009). Firestar: Computerized adaptive testing simulation program for polytomous item response theory models. Applied Psychological Measurement, 33(8), 644–645. CrossRef
Cohen, J. (1988). Statistical power analysis for the behavioral sciences (2nd ed.). New York: Academic Press.
Carlozzi, N. E., Downing, N. R., McCormack, M. K., Schilling, S. G., Perlmutter, J. S., Hahn, E. A., Lai, J.-S., Frank, S., Quaid, K. A., Paulsen, J. S., Cella, D., Goodnight, S. M., Miner, J. A., & Nance, M. A. (Under Review). New measures to capture end of life concerns in Huntington disease: Meaning and purpose and concern with death and dying from HDQLIFE (a patient reported outcomes measurement system). Quality of Life Research.
Carlozzi, N. E., Schilling, S. G., Lai, J.-S., Perlmutter, J. S., Nance, M. A., Waljee, J. F., Miner, J. A., Barton, S. K., Goodnight, S. M., & Dayalu, P. (Under Review). HDQLIFE: The development of two new computer adaptive tests, speech difficulties and swallowing difficulties. Quality of Life Research.
Folstein, S. E. (1989). Huntington’s disease: A disorder of families. Baltimore: Johns Hopkins University Press.
Hayden, M. R., MacGregor, J. M., & Beighton, P. H. (1980). The prevalence of Huntington’s chorea in South Africa. South African Medical Journal, 58, 193–196. PubMed
Narabayashi, H. (1973). Huntington’s chorea in Japan: Review of the literature. Advances in Neurology, 1, 253–259.
Tabrizi, S. J., Langbehn, D. R., Leavitt, B. R., Roos, R. A., Durr, A., Craufurd, D., et al. (2009). Biological and clinical manifestations of Huntington’s disease in the longitudinal TRACK-HD study: Cross-sectional analysis of baseline data. Lancet Neurology, 8(9), 791–801. CrossRefPubMedPubMedCentral
- The development of a new computer adaptive test to evaluate chorea in Huntington disease: HDQLIFE Chorea
N. E. Carlozzi
N. R. Downing
S. G. Schilling
S. M. Goodnight
J. A. Miner
S. A. Frank
- Springer International Publishing